2f DCK Psychonautwiki

1. Chemical name: 2-Fluorodeschloroketamine (2F-DCK)
2. Class: Dissociative anesthetic (arylcyclohexylamine)
3. Status: Research chemical; not approved as a medicine
4. Mechanism: Believed to act primarily as an NMDA receptor antagonist, although its full pharmacological profile is not completely characterized.

Reported Effects

Users have reported effects such as:

1. Dissociation
2. Altered sensory perception
3. Reduced perception of pain
4. Changes in mood
5. Impaired coordination and balance
6. Cognitive impairment

Individual responses vary considerably depending on dose, setting, and personal factors.

Risks

Potential risks include:

1. Confusion and impaired judgment
2. Accidents due to impaired coordination
3. Elevated heart rate and blood pressure
4. Nausea or vomiting
5. Psychological distress, anxiety, or panic
6. Unknown long-term health effects because of limited research

Combining dissociatives with alcohol, opioids, benzodiazepines, or other central nervous system depressants can substantially increase the risk of serious adverse effects.

Legal Status

The legal status of 2F-DCK varies by country. In many jurisdictions, it is controlled or falls under analogue or psychoactive substance legislation.

Research Status

There is relatively little peer-reviewed human research on 2F-DCK compared with ketamine. Most publicly available information comes from case reports, forensic analyses, and user reports, which should not be considered a substitute for controlled scientific studies.